Toll Free: 1-888-928-9744

Sevion Therapeutics, Inc. - Product Pipeline Review - 2015

Published: Dec, 2015 | Pages: 24 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Sevion Therapeutics, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Sevion Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Sevion Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sevion Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Sevion Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Sevion Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Sevion Therapeutics, Inc.'s pipeline products

Reasons to Buy

- Evaluate Sevion Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Sevion Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Sevion Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Sevion Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sevion Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Sevion Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Sevion Therapeutics, Inc. Snapshot 4 Sevion Therapeutics, Inc. Overview 4 Key Information 4 Key Facts 4 Sevion Therapeutics, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Sevion Therapeutics, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Sevion Therapeutics, Inc. - Pipeline Products Glance 9 Sevion Therapeutics, Inc. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Sevion Therapeutics, Inc. - Drug Profiles 11 insulin human 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 SVN-001 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 SVN-002 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Monoclonal Antibodies to Modulate GPCR for Cancer 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Monoclonal Antibody to Inhibit DLL4 for Cancer 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Monoclonal Antibody to Modulate Ion Channel for Pain 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Sevion Therapeutics, Inc. - Pipeline Analysis 17 Sevion Therapeutics, Inc. - Pipeline Products by Target 17 Sevion Therapeutics, Inc. - Pipeline Products by Molecule Type 18 Sevion Therapeutics, Inc. - Pipeline Products by Mechanism of Action 19 Sevion Therapeutics, Inc. - Dormant Projects 20 Sevion Therapeutics, Inc. - Discontinued Pipeline Products 21 Discontinued Pipeline Product Profiles 21 SNS-01T 21 Sevion Therapeutics, Inc. - Locations And Subsidiaries 22 Head Office 22 Other Locations & Subsidiaries 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 23 Disclaimer 24
List of Tables
Sevion Therapeutics, Inc., Key Information 4 Sevion Therapeutics, Inc., Key Facts 4 Sevion Therapeutics, Inc. - Pipeline by Indication, 2015 6 Sevion Therapeutics, Inc. - Pipeline by Stage of Development, 2015 7 Sevion Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015 8 Sevion Therapeutics, Inc. - Preclinical, 2015 9 Sevion Therapeutics, Inc. - Discovery, 2015 10 Sevion Therapeutics, Inc. - Pipeline by Target, 2015 17 Sevion Therapeutics, Inc. - Pipeline by Molecule Type, 2015 18 Sevion Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015 19 Sevion Therapeutics, Inc. - Dormant Developmental Projects,2015 20 Sevion Therapeutics, Inc. - Discontinued Pipeline Products, 2015 21 Sevion Therapeutics, Inc., Subsidiaries 22



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify